RAO Partner

Rare As One Partner

Three individuals sit on stage in a panel conversation at the RARE Health Equity Summit conference.
L-R: Linda Goler Blount, President & CEO, BWHI, Craig Martin, CEO, Global Genes, and Tammy Boyd, Chief Policy Officer & Counsel, BWHI, speak at the RARE Health Equity Summit, hosted by Global Genes in partnership with RDDC in November 2021.
L-R: Linda Goler Blount, President & CEO, BWHI, Craig Martin, CEO, Global Genes, and Tammy Boyd, Chief Policy Officer & Counsel, BWHI, speak at the RARE Health Equity Summit, hosted by Global Genes in partnership with RDDC in November 2021.

Black Women’s Health Imperative, Rare Disease Diversity Coalition

The Rare Disease Diversity Coalition (RDDC) is a partnership of rare disease experts, patient and provider organizations, and health equity advocates working to address the extraordinary challenges faced by rare disease patients of color. Launched in 2020, the RDDC and its partners are committed to being a catalyst for rare disease patients of color and the extraordinary challenges they face, seeking solutions on diversity in research and clinical trials, in the healthcare workforce, improving access and coverage, and increasing provider and patient engagement. As rare disease patients, they strive to be included (and not forgotten) in healthcare; and, as people of color, they fight daily for equity—against the reality of historic bias and its lingering disparate social, economic, and health effects. RDDC seeks to identify and advocate for evidenced-based solutions to alleviate the disproportionate burden of rare diseases on these communities.

Learn How We Support Science

Science Funding

Learn more about funding apportunities.

Hear Rare Disease Stories

Hear Rare Disease Stories

Listen to The Story Collider podcast featuring stories about patients who are driving progress against rare disease.